hazard
By:
Totie Mesia
Date:
Wednesday, September 17th, 2008
More than thirty (30) drugs which include acyclovir, cirprofloxacin and simvastatin, manufactured in two Ranbaxy Laboratories (Dewas and Poenta Sahib plants) in India will not be permitted into the US.
By:
Totie Mesia
Date:
Wednesday, September 17th, 2008
More than thirty (30) drugs which include acyclovir, cirprofloxacin and simvastatin, manufactured in two Ranbaxy Laboratories (Dewas and Poenta Sahib plants) in India will not be permitted into the US.